NSE ScannerComparison · NSE · data 2026-11-01
Amrutanjan Health Care Limited vs Sudeep Pharma Limited
In plain words
Size: Sudeep Pharma Limited is about 8.3 times the market value of Amrutanjan Health Care Limited.
Valuation (P/E): Sudeep Pharma Limited 64.1 vs Amrutanjan Health Care Limited 26.6.
Return on equity: Sudeep Pharma Limited 25.1% vs Amrutanjan Health Care Limited 16.6%.
Profit growth over 3 years: Sudeep Pharma Limited 40.5% a year vs Amrutanjan Health Care Limited 13.3% a year.
Debt to equity: Sudeep Pharma Limited 0.17 vs Amrutanjan Health Care Limited 0.
Differences in the numbers, not a recommendation of either stock.
Side by side
| AMRUTANJAN | SUDEEPPHRM | |
|---|---|---|
| Price | ₹496.65 | ₹1,068.3 |
| Market cap | ₹1,452 cr | ₹12,048 cr |
| P/E | 26.6 | 64.1 |
| P/B | — | 12.6 |
| ROE | 16.6% | 25.1% |
| ROCE | 17.9% | 28.4% |
| Debt / equity | 0 | 0.17 |
| Operating margin | 11.6% | 32.9% |
| Dividend yield | 0.99% | 0.14% |
| Sales growth, 3 years (yearly) | 9.8% | 14.4% |
| Profit growth, 3 years (yearly) | 13.3% | 40.5% |
| 1-year return | -33.0% | 46.3% |
| Revenue, last 12 months | ₹511 cr | ₹710 cr |
| Net profit, last 12 months | ₹54 cr | ₹188 cr |
| Latest quarter | Jun 2026 | Sept 2026 |
| Quarter net profit | ₹4 cr | ₹52 cr |
| Quarter profit vs a year earlier | -47.4% | +13.2% |
| Promoter holding | 46.52% | 76.15% |
| Health check | Average (5.7/10) | Strong (6.8/10) |
Common questions
Which has a higher P/E, Amrutanjan Health Care Limited or Sudeep Pharma Limited?
Sudeep Pharma Limited trades at the higher P/E (64.1 against 26.6). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Sudeep Pharma Limited (25.1% against 16.6%).
Which carries more debt?
Sudeep Pharma Limited has the higher debt-to-equity ratio (0.17 against 0).